Food/beverage, healthcare the best performers; travel/leisure the main laggards:
StreetAccount Summary - Trading higher/lower: EU mid-morning
Sartorius Stedim Biotech reports 9M EPS €2.24 vs year-ago €1.34. Raising FY guidance (€185.95, 0.00)
Powered by FactSet Research Systems Inc.